Aesthetic Medical International Holdings Group Ltd ADR’s (AIH) Stock: A Week-by-Week Analysis

The stock of Aesthetic Medical International Holdings Group Ltd ADR (AIH) has seen a -2.75% decrease in the past week, with a -32.12% drop in the past month, and a -48.58% decrease in the past quarter. The volatility ratio for the week is 7.59%, and the volatility levels for the past 30 days are at 9.47% for AIH. The simple moving average for the past 20 days is -13.36% for AIH’s stock, with a -52.29% simple moving average for the past 200 days.

Is It Worth Investing in Aesthetic Medical International Holdings Group Ltd ADR (NASDAQ: AIH) Right Now?

The 36-month beta value for AIH is also noteworthy at -0.03. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The public float for AIH is 43.16M, and at present, short sellers hold a 0.08% of that float. The average trading volume of AIH on April 03, 2024 was 43.12K shares.

AIH) stock’s latest price update

Aesthetic Medical International Holdings Group Ltd ADR (NASDAQ: AIH)’s stock price has increased by 13.13 compared to its previous closing price of 0.30. However, the company has seen a -2.75% decrease in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-05-11 that SHENZHEN, China, May 11, 2023 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the first quarter of 2023 before the U.S. market opens on Wednesday, May 17, 2023.

AIH Trading at -27.01% from the 50-Day Moving Average

After a stumble in the market that brought AIH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.27% of loss for the given period.

Volatility was left at 9.47%, however, over the last 30 days, the volatility rate increased by 7.59%, as shares sank -37.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -44.36% lower at present.

During the last 5 trading sessions, AIH fell by -2.75%, which changed the moving average for the period of 200-days by -63.27% in comparison to the 20-day moving average, which settled at $0.3817. In addition, Aesthetic Medical International Holdings Group Ltd ADR saw -50.78% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for AIH

Current profitability levels for the company are sitting at:

  • -0.08 for the present operating margin
  • 0.51 for the gross margin

The net margin for Aesthetic Medical International Holdings Group Ltd ADR stands at -0.04. The total capital return value is set at -0.43.

Based on Aesthetic Medical International Holdings Group Ltd ADR (AIH), the company’s capital structure generated 0.87 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 6.95. The interest coverage ratio of the stock is -2.16.

Currently, EBITDA for the company is -11.05 million with net debt to EBITDA at -7.92. When we switch over and look at the enterprise to sales, we see a ratio of 0.41. The receivables turnover for the company is 18.96for trailing twelve months and the total asset turnover is 1.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.35.

Conclusion

In summary, Aesthetic Medical International Holdings Group Ltd ADR (AIH) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts